Regular monthly check-ins with your Klinic representative help manage your dosing and address any queries you might have
This is an important study because its the first time a weight loss drug has been shown to reduce the risk of heart disease, including the risk of death, says Howard Weintraub, MD, clinical director of the Center for the Prevention of Cardiovascular Disease, part of NYU Langone Heart
Tirzepatide is a research compound currently being explored in metabolic and GLP-related studies
How do we protect people who are searching for answers from misleading or predatory marketing
Before switching, discuss with your healthcare provider your current weight loss plateau, specific side effects, blood glucose control, and any other medications or conditions
Mar 2013;30 Suppl:S109-116